Ikena Oncology (IKNA): Market Value

Graphic logo of Ikena Oncology, Inc. (IKNA)

Ikena Oncology, Inc. (IKNA) adheres to environmental standards by implementing energy saving and filtration systems within its laboratories. This chart illustrates that the asset's market value is 0.07. The company's potential is based on patents for the IK-930 molecule, which blocks Hippo-YAP in tumors, although the lack of commercialized products results in a steady cash burn for research needs.

Ikena Oncology - IKNA Market Capitalization (period 07/04/2022 - 08/09/2025)

Metric breakdowns and analytics for Ikena Oncology Inc. (IKNA)

- stock exchange capitalization data:
Fundamental company valuation:Ikena Oncology IKNA
Product sample of Ikena Oncology

Asset value dynamics depend directly on operational efficiency and market expectations. The market capitalization of Ikena Oncology, Inc. (IKNA) reflects the aggregate exchange valuation of the business, allowing for the timely detection of trend reversals. For a biotech startup like Ikena Oncology, Inc. (IKNA) with a minimal environmental footprint and a laboratory focus, this metric measures investor confidence in the success of its drug pipeline. Analyzing the market capitalization of Ikena Oncology, Inc. (IKNA) helps distinguish fair valuation from false discounts.

Competitors of Ikena Oncology, Inc. (IKNA)

Market Value BeiGene Ltd ONC|Market Capitalization Halozyme Corp HALO|RVMD - Market Value|Market Valuation AAPG|CG Oncology Corp (CGON) - Market Value|Market Capitalization URGN|BCAX (Bicara Corp) - Market Capitalization|Market Valuation Personalis Corp (PSNL)|Market Capitalization ERAS|Market Capitalization delcath.com (DCTH)|Market Value YmAbs YMAB|AURA: Market Capitalization|Candel Therapeutics, Inc. - Market Capitalization|Accuray Inc. (ARAY) - Market Valuation|SELLAS Life Sciences Group Inc. (SLS) - Market Value|Market Value actuatetherapeutics.com (ACTU)|Market Value Citius Oncology|HURA: Market Value|Market Valuation TARA (Protara)|FATE (Fate Therapeutics Corp) - Market Value|Market Capitalization WHWK (Aadi Bioscience Inc)|TCRX - Market Valuation|CSBR: Market Valuation|XBIT - Market Capitalization|CVM: Market Capitalization|OS Therapies Inc - Market Value|RADX (radiopharmtheranostics.com) - Market Capitalization|Market Value Artiva Biotherapeutics, Inc. ARTV|Market Capitalization ANL|Market Value VERU (Veru)|Market Capitalization TPST (tempesttx.com)|Xilio - Market Value|RENB - Market Value|Market Value MURA (muraloncology.com)|Kairos Pharma Inc (KAPA) - Market Value|OnKure (OKUR) - Market Capitalization|Market Value w2.cytomed.sg|Curis (CRIS) - Market Capitalization|Market Value Apollomics, Inc. (APLM)|Market Valuation tharimmune.com THAR|Market Capitalization ADVB (Advanced Biomed)|GNPX: Market Capitalization|calidibio.com - Market Capitalization|Market Value Sunshine Biopharma|XBIO: Market Capitalization|salariuspharma.com - Market Value|Market Value Kitov Pharma|Market Value aoncology.com AONC|Market Capitalization BGNE|CKPT (Checkpoint Therapeutics) - Market Value|Market Value Elevation Oncology ELEV|Market Capitalization iCAD Corp ICAD|NTBL: Market Valuation|VIRX - Market Capitalization|MorphoSys Corp (MOR) - Market Value|Market Valuation NAYA Bio|Market Value Ascentage Pharma Group